Literature DB >> 18680279

Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor.

Chris de Graaf1, Didier Rognan.   

Abstract

The recently solved high-resolution X-ray structure of the beta2 adrenergic receptor has been challenged for its ability to discriminate inverse agonists/antagonists from partial/full agonists. Whereas the X-ray structure of the ground state receptor was unsuitable to distinguish true ligands with different functional effects, modifying this structure to reflect early conformational events in receptor activation led to a receptor model able to selectively retrieve full and partial agonists by structure-based virtual screening. The use of a topological scoring function based on molecular interaction fingerprints was shown to be mandatory to properly rank docking poses and achieve acceptable enrichments for partial and full agonists only.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680279     DOI: 10.1021/jm800710x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  45 in total

1.  Towards predictive docking at aminergic G-protein coupled receptors.

Authors:  Jan Jakubík; Esam E El-Fakahany; Vladimír Doležal
Journal:  J Mol Model       Date:  2015-10-09       Impact factor: 1.810

2.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

Authors:  Chris de Graaf; Albert J Kooistra; Henry F Vischer; Vsevolod Katritch; Martien Kuijer; Mitsunori Shiroishi; So Iwata; Tatsuro Shimamura; Raymond C Stevens; Iwan J P de Esch; Rob Leurs
Journal:  J Med Chem       Date:  2011-11-07       Impact factor: 7.446

Review 3.  Recent advances in structure-based virtual screening of G-protein coupled receptors.

Authors:  Subramaniam Ananthan; Wei Zhang; Judith Varady Hobrath
Journal:  AAPS J       Date:  2009-03-17       Impact factor: 4.009

4.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

5.  Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.

Authors:  J Robert Lane; Pavel Chubukov; Wei Liu; Meritxell Canals; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Vsevolod Katritch
Journal:  Mol Pharmacol       Date:  2013-09-10       Impact factor: 4.436

6.  Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptor.

Authors:  Santiago Vilar; Joel Karpiak; Stefano Costanzi
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

7.  Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.

Authors:  Jeffrey J Liu; Reto Horst; Vsevolod Katritch; Raymond C Stevens; Kurt Wüthrich
Journal:  Science       Date:  2012-01-19       Impact factor: 47.728

8.  Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.

Authors:  Kimberly A Reynolds; Vsevolod Katritch; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2009-01-16       Impact factor: 3.686

9.  Structure-based discovery of A2A adenosine receptor ligands.

Authors:  Jens Carlsson; Lena Yoo; Zhan-Guo Gao; John J Irwin; Brian K Shoichet; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

10.  Docking studies on a refined human beta(2) adrenoceptor model yield theoretical affinity values in function with experimental values for R-ligands, but not for S-antagonists.

Authors:  Marvin A Soriano-Ursúa; José G Trujillo-Ferrara; Jesús Alvarez-Cedillo; José Correa-Basurto
Journal:  J Mol Model       Date:  2009-07-22       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.